Literature DB >> 421042

Amitriptyline plasma concentration and clinical response.

S A Montgomery, R McAuley, S J Rani, D B Montgomery, R Braithwaite, S Dawling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421042      PMCID: PMC1597810          DOI: 10.1136/bmj.1.6158.230-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Plasma concentration of amitriptyline and clinical response.

Authors:  R A Braithwaite; R Goulding; G Theano; J Bailey; A Coppen
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

2.  A comparison study of amitriptyline and nortriptyline with plasma levels.

Authors:  V E Ziegler; P J Clayton; J T Biggs
Journal:  Arch Gen Psychiatry       Date:  1977-05

3.  Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.

Authors:  A Coppen; K Ghose; S Montgomery; V A Rama Rao; J Bailey; J Christiansen; P L Mikkleson; H M van Praag; F van de Poel; E J Minsker; V G Kozulja; N Matussek; G Kungkunz; A Jłrgensen
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

  3 in total
  17 in total

1.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.

Authors:  M L Rao
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

4.  Therapeutic window for amitriptyline analgesia.

Authors:  C P Watson
Journal:  Can Med Assoc J       Date:  1984-01-15       Impact factor: 8.262

5.  Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.

Authors:  B Vandel; M Sandoz; S Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 6.  Amoxapine: a review of its pharmacology and efficacy in depressed states.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

Review 7.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

8.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

9.  Biotransformation of amitriptyline in alcoholic depressive patients.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.

Authors:  G M Simpson; E H Pi; E Abdelmalek; J L Boyd; R S Carroll; T B Cooper; A Miller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.